Template:Percutaneous Coronary Intervention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 58: | Line 58: | ||
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Bleeding Risk|Bleeding Risk]] | :[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Bleeding Risk|Bleeding Risk]] | ||
: | :Role of Onsite Surgical Backup: | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Primary PCI in Hospitals Without On-Site Surgical Backup|Primary PCI in Hospitals Without On-Site Surgical Backup]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Primary PCI in Hospitals Without On-Site Surgical Backup|Primary PCI in Hospitals Without On-Site Surgical Backup]] | ||
| Line 72: | Line 72: | ||
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Vascular Access|Vascular Access]] | :[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Vascular Access|Vascular Access]] | ||
: | :PCI in Specific Clinical Situations: | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Patients With Asymptomatic Ischemia or CCS Class I or II Angina|PCI in patients with Asymptomatic Ischemia or CCS Class I or II Angina]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Patients With Asymptomatic Ischemia or CCS Class I or II Angina|PCI in patients with Asymptomatic Ischemia or CCS Class I or II Angina]] | ||
| Line 80: | Line 80: | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction|PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction|PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction]] | ||
:: | ::PCI in patients with ST-Elevation Myocardial Infarction: | ||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Angiography Strategies in STEMI|Coronary Angiography Strategies in STEMI]] | :::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Angiography Strategies in STEMI|Coronary Angiography Strategies in STEMI]] | ||
| Line 98: | Line 98: | ||
:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion|PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion]] | :::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion|PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion]] | ||
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Cardiogenic Shock|PCI in patients with Cardiogenic Shock]] | |||
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Prior Coronary Bypass Surgery|PCI in patients with Prior Coronary Bypass Surgery]] | |||
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Revascularization Before Non-cardiac Surgery|Revascularization Before Non-cardiac Surgery]] | |||
:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Stents|Coronary Stents]] | :[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Stents|Coronary Stents]] | ||
| Line 140: | Line 140: | ||
:Anticoagulant Therapy: | :Anticoagulant Therapy: | ||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Use of Parenteral Anticoagulants during PCI|Parenteral Anticoagulants During PCI]] | |||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Unfractionated Heparin|Unfractionated Heparin]] | |||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Enoxaparin|Enoxaparin]] | |||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Bivalirudin and Argatoban|Bivalirudin and Argatroban]] | |||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Fondaparinux|Fondaparinux]] | |||
::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#No-Reflow Pharmacological Therapies|No-Reflow Pharmacological Therapies]] | ::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#No-Reflow Pharmacological Therapies|No-Reflow Pharmacological Therapies]] | ||
Revision as of 17:07, 19 December 2011
|
Percutaneous Coronary Intervention Microchapters |
|
Guideline Recommendations |
|---|
|
CAD Revascularization: |
|
Pre-procedural Considerations:
|
|
Procedural Considerations:
|
|
Post-Procedural Considerations: |
|
Quality and Performance Considerations: |
|
Percutaneous Coronary Intervention On the Web |
|
American Roentgen Ray Society Images of Percutaneous Coronary Intervention |
|
Directions to Hospitals Treating Percutaneous Coronary Intervention |
|
Risk calculators and risk factors for Percutaneous Coronary Intervention |